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Patients who have too few functioning mature 
polymorphonuclear neutrophils frequently develop 
fatal bacterial or fungal infections despite our best 
efforts to prevent and treat those infections. Recently 
new facets of white cell function which enable us to 
better understand both normal and abnormal states 
have been found. Several review articles about poly­
morphonuclear neutrophils (also called neutrophils 
and granulocytes-the latter term includes eosino­
phils and basophils) have been published recently'-' 
and the reader is referred to these for more compre­
hensive coverage of the field. 
Development and Deployment of Neutrophils. 
Cells that have the potential to develop into the 
polymorphonuclear neutrophil series or into the 
monocyte-macrophage series are present in bone 
marrow. Those destined to be neutrophils go through 
a sequence of maturation steps lasting about two 
weeks. The early developing cells have a very rigid 
cell surface, are poorly motile, and cannot effectively 
engulf foreign particles. As they develop, gran­
ulocytes become progressively more flexible. more 
able to ingest foreign particles, and more efficient at 
phagocytosis and killing microbes. 
Mature polymorphonuclear neutrophils are con­
stantly released from the marrow into the circulation. 
Their half-life in the blood is about six to eight hours. 
After leaving the blood, polymorphonuclear neutro­
phils migrate to the tissues where they may live for 
several days before being destroyed. Neutrophils are 
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destroyed by fixed mononuclear phagocytes in such 
organs as the liver. spleen, lungs. and bone marrow. 
and others are excreted in the fecal stream. Hundreds 
of millions of granulocytes enter the bloodstream 
from the marrow and leave the bloodstream for the 
tissues each day. but only a small percentage of the 
body's total number of granulocytes circulates in the 
blood at any one time. This circulating pool contains 
between 3% to 5% of the total granulocyte popu­
lation. The vast majority of mature neutrophils are 
extravascular in tissues. or waiting to be released 
from the bone marrow. It is this latter pool that is the 
source of most of the increased numbers of circulat­
ing white cells in patients with acute bacterial in­
fection. There appear to be separate regulators of 
neutrophil proliferation. maturation. and release into 
the circulation. 
Morphology and Motility. 
The mature neutrophil is about 12 to 15 microns 
in diameter and contains a multilobed nucleus. The 
characteristic of the cell reponsible for the name 
"granulocyte" is the presence of multiple granules 
containing enzymes and preenzymes in the cy­
toplasm. Other organelles are less conspicuous and 
very little in the way of ribosomal structure or mito­
chondria can be seen. There is a large amount of 
cytoplasmic glycogen which can be utilized as an 
energy source. Both microtubules and microfilaments 
can be seen in the cell in special preparations. 
Neutrophils are actively motile when in contact 
with a solid surface: they crawl rather than swim. 
Motile polymorphonuclear neutrophils look very dif­
ferent from cells seen on a stained blood smear. They 
usually have a broad front with a thin edge of cy­
toplasm (the lamellipodia) followed by a slowly ta-
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pering. roughly triangular-shaped body and a knob­
like tail. Granules are not seen in the leading edge. 
but granules do move in the cytoplasm of the cell 
where they seem to travel in roughly-defined chan­
nels. There is evidence to support the concept that 
microtubules and microfilaments are responsible for 
cell movement. 
Phagocytosis. 
After mature neutrophils leave the bone marrow 
and enter the circulation. their mission is to leave the 
vascular system and migrate to areas where they are 
needed such as an area of infection or injury. In the 
first step in this process. called margination. neutro­
phils circulating through capillaries near the site of 
injury become sticky and adhere to endothelial cells 
lining small blood vessels. Anti-inflammatory drugs 
such as aspirin and prednisone inhibit granulocyte 
adherence. The phagocytes leave the blood vessels by 
crawling through the junction between endothelial 
cells. The neutrophils are then directed towards the 
site of microbial invasion by chemotaxis. a process in 
which factors from the region of microbial invasion 
attract neutrophils towards the greatest concentra­
tion of these factors. 
After neutrophils have migrated to tissue in­
vaded by microbes. they attempt to ingest susceptible 
microorganisms and destroy them. The first step is 
recognition of the microorganisms as foreign to the 
phagocyte and a target for phagocytosis. With some 
organisms high titers of specific antibody are required 
for this recognition while in others the so-called "nat­
ural antibody" or low level of antibody usually pres­
ent in normal serum is enough to stimulate phagocy­
tosis. The antibody itself may promote phagocytosis. 
but usually the combination of antibody plus com­
plement factors is optimum for promoting phagocy­
tosis. Only immunoglobulins of the IgG class are 
opsonic. 
When a neutrophil engulfs a microbe. the lead­
ing edge of the Jamellipodia makes initial contact 
(Figure) and pseudopods are sent out. cupping the 
microorganism. This cup closes by means of mem­
brane fusion which results in the microorganism 
being enclosed in a membrane-bound space. This 
space. called the phagosome. is bounded by the ex­
ternal cell membrane which becomes internalized in 
the process. The energy for phagocytosis and loco­
motion is derived largely through anaerobic gly­
colysis. and cells are able to move and engulf organ­
isms in an anaerobic atmosphere. 
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Figure-A series of phase contrast photomicrographs of a human 
polymorphonu(lear ncutrophil ingesting two clumps of Srrepto­
coccu., pyogenes (L,riginal magnification. X 1200). Photomicro­
graph h, James Sulli,an and Gerald Mandell. 
Leukocyte Bactericidal Activity. 
During and after phagocytosis. granules in the 
cytoplasm move towards phagosomes which contain 
ingested particles. The contents of the granules are 
extruded into the phagosome as the granule mem­
brane fuses with the phagosome membrane. The 
phagosome. now containing lysosomal and other en­
zymes from the granules. is called the phagolyso­
some. Degranulation enables these potent enzymes to 
contact ingested microbes in the phagosome without 
exposing the cytoplasm of the neutrophil to the pos­
sible deleterious effects of the enzymes. Granules 
"disappear" from the cell during this reaction. hence 
the term degranulation. 
Along with the events described above. changes 
occur in the metabolism of the neutrophil. the most 
dramatic of which is a marked stimulation of oxygen 
consumption. The products of this oxygen consump­
tion are oxidized forms of oxygen such as superoxide 
anion (0 2 ) and hydrogen peroxide (H20,). both of 
which possess antibacterial activities. The antibacte­
rial activity of hydrogen peroxide is markedly en­
hanced by the presence of myeloperoxidase and a 
halide. In the phagolysosome containing the ingested 
microbe one finds myeloperoxidase. hydrogen per­
oxide. and a halide. which in concert can kill the 
microorganisms. Bacterial death may be the result of 
a reaction which culminates in oxidation or haloge-
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nation, or both, or vital structures on the bacterial 
surface. 
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